 | • レポートコード：D0GIR-01735 • 出版社/出版日：GlobalInfoResearch / 2020年9月23日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、B型肝炎薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。B型肝炎薬の種類別市場規模（エンテカビル、テノホビル、ラミブジン、アデホビル、テルビブジン、その他）、用途別市場規模（病院薬局、小売薬局・ドラッグストア、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：GlaxoSmithKline、Novartis、Johnson & Johnson、Bristol-Myers Squibb、Merck & Co. Inc.、Mitsubishi Tanabe Pharma、Gilead Sciences、Roche、AbbVie ・地域別グローバル市場分析 2015年-2020年 ・B型肝炎薬の北米市場（アメリカ、カナダ、メキシコ） ・B型肝炎薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・B型肝炎薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・B型肝炎薬の南米市場（ブラジル、アルゼンチン） ・B型肝炎薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：エンテカビル、テノホビル、ラミブジン、アデホビル、テルビブジン、その他 ・用途別分析：病院薬局、小売薬局・ドラッグストア、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The Hepatitis B Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The most likely (base case) scenario is that the global Hepatitis B Drug sales will be xx in 2020 from Hepatitis B Drug million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global Hepatitis B Drug market size is expected to grow at xx% or more annually for the next five years.
This report also researches and evaluates the impact of Covid-19 outbreak on the Hepatitis B Drug industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Hepatitis B Drug and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).
Market segmentation
Hepatitis B Drug market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Hepatitis B Drug market has been segmented into:
Entecavir
Tenofovir
Lamivudine
Adefovir
Telbivudine
Others
By Application, Hepatitis B Drug has been segmented into:
Hospital Pharmacies
Retail Pharmacies & Drug Stores
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Hepatitis B Drug market presented in the report. This section sheds light on the sales growth of different regional and country-level Hepatitis B Drug markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Hepatitis B Drug market.
The report offers in-depth assessment of the growth and other aspects of the Hepatitis B Drug market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Hepatitis B Drug Market Share Analysis
Hepatitis B Drug competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Hepatitis B Drug sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Hepatitis B Drug sales, revenue and market share for each player covered in this report.
The major players covered in Hepatitis B Drug are:
GlaxoSmithKline
Novartis
Johnson & Johnson
Bristol-Myers Squibb
Merck & Co. Inc.
Mitsubishi Tanabe Pharma
Gilead Sciences
Roche
AbbVie
Among other players domestic and global, Hepatitis B Drug market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
1 Hepatitis B Drug Market Overview
1.1 Product Overview and Scope of Hepatitis B Drug
1.2 Classification of Hepatitis B Drug by Type
1.2.1 Global Hepatitis B Drug Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Hepatitis B Drug Revenue Market Share by Type in 2019
1.2.3 Entecavir
1.2.4 Tenofovir
1.2.5 Lamivudine
1.2.6 Adefovir
1.2.7 Telbivudine
1.2.8 Others
1.3 Global Hepatitis B Drug Market by Application
1.3.1 Overview: Global Hepatitis B Drug Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies & Drug Stores
1.3.4 Others
1.4 Global Hepatitis B Drug Market by Regions
1.4.1 Global Hepatitis B Drug Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Hepatitis B Drug (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Hepatitis B Drug Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Hepatitis B Drug Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Hepatitis B Drug Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Hepatitis B Drug Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Hepatitis B Drug Status and Prospect (2015-2025)
1.5 COVID-19 Outbreak: Hepatitis B Drug Industry Impact
1.5.1 COVID-19 Potential Implications for the Hepatitis B Drug
1.5.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on Hepatitis B Drug
1.5.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.5.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.5.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.5.2 Opportunity Analysis in Covid-19 Crisis
1.5.3 Market Risk and Restraints
1.5.4 Market Driving Force
2 Company Profiles
2.1 GlaxoSmithKline
2.1.1 GlaxoSmithKline Details
2.1.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 GlaxoSmithKline SWOT Analysis
2.1.4 GlaxoSmithKline Product and Services
2.1.5 GlaxoSmithKline Hepatitis B Drug Revenue, Gross Margin and Market Share (2018-2019)
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Novartis SWOT Analysis
2.2.4 Novartis Product and Services
2.2.5 Novartis Hepatitis B Drug Revenue, Gross Margin and Market Share (2018-2019)
2.3 Johnson & Johnson
2.3.1 Johnson & Johnson Details
2.3.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Johnson & Johnson SWOT Analysis
2.3.4 Johnson & Johnson Product and Services
2.3.5 Johnson & Johnson Hepatitis B Drug Revenue, Gross Margin and Market Share (2018-2019)
2.4 Bristol-Myers Squibb
2.4.1 Bristol-Myers Squibb Details
2.4.2 Bristol-Myers Squibb Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Bristol-Myers Squibb SWOT Analysis
2.4.4 Bristol-Myers Squibb Product and Services
2.4.5 Bristol-Myers Squibb Hepatitis B Drug Revenue, Gross Margin and Market Share (2018-2019)
2.5 Merck & Co. Inc.
2.5.1 Merck & Co. Inc. Details
2.5.2 Merck & Co. Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Merck & Co. Inc. SWOT Analysis
2.5.4 Merck & Co. Inc. Product and Services
2.5.5 Merck & Co. Inc. Hepatitis B Drug Revenue, Gross Margin and Market Share (2018-2019)
2.6 Mitsubishi Tanabe Pharma
2.6.1 Mitsubishi Tanabe Pharma Details
2.6.2 Mitsubishi Tanabe Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Mitsubishi Tanabe Pharma SWOT Analysis
2.6.4 Mitsubishi Tanabe Pharma Product and Services
2.6.5 Mitsubishi Tanabe Pharma Hepatitis B Drug Revenue, Gross Margin and Market Share (2018-2019)
2.7 Gilead Sciences
2.7.1 Gilead Sciences Details
2.7.2 Gilead Sciences Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Gilead Sciences SWOT Analysis
2.7.4 Gilead Sciences Product and Services
2.7.5 Gilead Sciences Hepatitis B Drug Revenue, Gross Margin and Market Share (2018-2019)
2.8 Roche
2.8.1 Roche Details
2.8.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Roche SWOT Analysis
2.8.4 Roche Product and Services
2.8.5 Roche Hepatitis B Drug Revenue, Gross Margin and Market Share (2018-2019)
2.9 AbbVie
2.9.1 AbbVie Details
2.9.2 AbbVie Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 AbbVie SWOT Analysis
2.9.4 AbbVie Product and Services
2.9.5 AbbVie Hepatitis B Drug Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Hepatitis B Drug Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Hepatitis B Drug Players Market Share
3.2.2 Top 10 Hepatitis B Drug Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Hepatitis B Drug Revenue and Market Share by Regions
4.2 North America Hepatitis B Drug Revenue and Growth Rate (2015-2020)
4.3 Europe Hepatitis B Drug Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Hepatitis B Drug Revenue and Growth Rate (2015-2020)
4.5 South America Hepatitis B Drug Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Hepatitis B Drug Revenue and Growth Rate (2015-2020)
5 North America Hepatitis B Drug Revenue by Countries
5.1 North America Hepatitis B Drug Revenue by Countries (2015-2020)
5.2 USA Hepatitis B Drug Revenue and Growth Rate (2015-2020)
5.3 Canada Hepatitis B Drug Revenue and Growth Rate (2015-2020)
5.4 Mexico Hepatitis B Drug Revenue and Growth Rate (2015-2020)
6 Europe Hepatitis B Drug Revenue by Countries
6.1 Europe Hepatitis B Drug Revenue by Countries (2015-2020)
6.2 Germany Hepatitis B Drug Revenue and Growth Rate (2015-2020)
6.3 UK Hepatitis B Drug Revenue and Growth Rate (2015-2020)
6.4 France Hepatitis B Drug Revenue and Growth Rate (2015-2020)
6.5 Russia Hepatitis B Drug Revenue and Growth Rate (2015-2020)
6.6 Italy Hepatitis B Drug Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Hepatitis B Drug Revenue by Countries
7.1 Asia-Pacific Hepatitis B Drug Revenue by Countries (2015-2020)
7.2 China Hepatitis B Drug Revenue and Growth Rate (2015-2020)
7.3 Japan Hepatitis B Drug Revenue and Growth Rate (2015-2020)
7.4 Korea Hepatitis B Drug Revenue and Growth Rate (2015-2020)
7.5 India Hepatitis B Drug Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Hepatitis B Drug Revenue and Growth Rate (2015-2020)
8 South America Hepatitis B Drug Revenue by Countries
8.1 South America Hepatitis B Drug Revenue by Countries (2015-2020)
8.2 Brazil Hepatitis B Drug Revenue and Growth Rate (2015-2020)
8.3 Argentina Hepatitis B Drug Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Hepatitis B Drug by Countries
9.1 Middle East & Africa Hepatitis B Drug Revenue by Countries (2015-2020)
9.2 Saudi Arabia Hepatitis B Drug Revenue and Growth Rate (2015-2020)
9.3 UAE Hepatitis B Drug Revenue and Growth Rate (2015-2020)
9.4 Egypt Hepatitis B Drug Revenue and Growth Rate (2015-2020)
9.5 South Africa Hepatitis B Drug Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Hepatitis B Drug Revenue and Market Share by Type (2015-2020)
10.2 Global Hepatitis B Drug Market Forecast by Type (2019-2024)
10.3 Entecavir Revenue Growth Rate (2015-2025)
10.4 Tenofovir Revenue Growth Rate (2015-2025)
10.5 Lamivudine Revenue Growth Rate (2015-2025)
10.6 Adefovir Revenue Growth Rate (2015-2025)
10.7 Telbivudine Revenue Growth Rate (2015-2025)
10.8 Others Revenue Growth Rate (2015-2025)
11 Global Hepatitis B Drug Market Segment by Application
11.1 Global Hepatitis B Drug Revenue Market Share by Application (2015-2020)
11.2 Hepatitis B Drug Market Forecast by Application (2019-2024)
11.3 Hospital Pharmacies Revenue Growth (2015-2020)
11.4 Retail Pharmacies & Drug Stores Revenue Growth (2015-2020)
11.5 Others Revenue Growth (2015-2020)
12 Global Hepatitis B Drug Market Size Forecast (2021-2025)
12.1 Global Hepatitis B Drug Market Size Forecast (2021-2025)
12.2 Global Hepatitis B Drug Market Forecast by Regions (2021-2025)
12.3 North America Hepatitis B Drug Revenue Market Forecast (2021-2025)
12.4 Europe Hepatitis B Drug Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Hepatitis B Drug Revenue Market Forecast (2021-2025)
12.6 South America Hepatitis B Drug Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Hepatitis B Drug Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Hepatitis B Drug Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Hepatitis B Drug by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Hepatitis B Drug Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Hepatitis B Drug Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Hepatitis B Drug Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. GlaxoSmithKline Corporate Information, Location and Competitors
Table 7. GlaxoSmithKline Hepatitis B Drug Major Business
Table 8. GlaxoSmithKline Hepatitis B Drug Total Revenue (USD Million) (2017-2018)
Table 9. GlaxoSmithKline SWOT Analysis
Table 10. GlaxoSmithKline Hepatitis B Drug Product and Solutions
Table 11. GlaxoSmithKline Hepatitis B Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. Novartis Corporate Information, Location and Competitors
Table 13. Novartis Hepatitis B Drug Major Business
Table 14. Novartis Hepatitis B Drug Total Revenue (USD Million) (2018-2019)
Table 15. Novartis SWOT Analysis
Table 16. Novartis Hepatitis B Drug Product and Solutions
Table 17. Novartis Hepatitis B Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. Johnson & Johnson Corporate Information, Location and Competitors
Table 19. Johnson & Johnson Hepatitis B Drug Major Business
Table 20. Johnson & Johnson Hepatitis B Drug Total Revenue (USD Million) (2017-2018)
Table 21. Johnson & Johnson SWOT Analysis
Table 22. Johnson & Johnson Hepatitis B Drug Product and Solutions
Table 23. Johnson & Johnson Hepatitis B Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Bristol-Myers Squibb Corporate Information, Location and Competitors
Table 25. Bristol-Myers Squibb Hepatitis B Drug Major Business
Table 26. Bristol-Myers Squibb Hepatitis B Drug Total Revenue (USD Million) (2017-2018)
Table 27. Bristol-Myers Squibb SWOT Analysis
Table 28. Bristol-Myers Squibb Hepatitis B Drug Product and Solutions
Table 29. Bristol-Myers Squibb Hepatitis B Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. Merck & Co. Inc. Corporate Information, Location and Competitors
Table 31. Merck & Co. Inc. Hepatitis B Drug Major Business
Table 32. Merck & Co. Inc. Hepatitis B Drug Total Revenue (USD Million) (2017-2018)
Table 33. Merck & Co. Inc. SWOT Analysis
Table 34. Merck & Co. Inc. Hepatitis B Drug Product and Solutions
Table 35. Merck & Co. Inc. Hepatitis B Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Mitsubishi Tanabe Pharma Corporate Information, Location and Competitors
Table 37. Mitsubishi Tanabe Pharma Hepatitis B Drug Major Business
Table 38. Mitsubishi Tanabe Pharma Hepatitis B Drug Total Revenue (USD Million) (2017-2018)
Table 39. Mitsubishi Tanabe Pharma SWOT Analysis
Table 40. Mitsubishi Tanabe Pharma Hepatitis B Drug Product and Solutions
Table 41. Mitsubishi Tanabe Pharma Hepatitis B Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Gilead Sciences Corporate Information, Location and Competitors
Table 43. Gilead Sciences Hepatitis B Drug Major Business
Table 44. Gilead Sciences Hepatitis B Drug Total Revenue (USD Million) (2017-2018)
Table 45. Gilead Sciences SWOT Analysis
Table 46. Gilead Sciences Hepatitis B Drug Product and Solutions
Table 47. Gilead Sciences Hepatitis B Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. Roche Corporate Information, Location and Competitors
Table 49. Roche Hepatitis B Drug Major Business
Table 50. Roche Hepatitis B Drug Total Revenue (USD Million) (2017-2018)
Table 51. Roche SWOT Analysis
Table 52. Roche Hepatitis B Drug Product and Solutions
Table 53. Roche Hepatitis B Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. AbbVie Corporate Information, Location and Competitors
Table 55. AbbVie Hepatitis B Drug Major Business
Table 56. AbbVie Hepatitis B Drug Total Revenue (USD Million) (2017-2018)
Table 57. AbbVie SWOT Analysis
Table 58. AbbVie Hepatitis B Drug Product and Solutions
Table 59. AbbVie Hepatitis B Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 60. Global Hepatitis B Drug Revenue (Million USD) by Players (2015-2020)
Table 61. Global Hepatitis B Drug Revenue Share by Players (2015-2020)
Table 62. Global Hepatitis B Drug Revenue (Million USD) by Regions (2015-2020)
Table 63. Global Hepatitis B Drug Revenue Market Share by Regions (2015-2020)
Table 64. North America Hepatitis B Drug Revenue by Countries (2015-2020)
Table 65. North America Hepatitis B Drug Revenue Market Share by Countries (2015-2020)
Table 66. Europe Hepatitis B Drug Revenue (Million USD) by Countries (2015-2020)
Table 67. Asia-Pacific Hepatitis B Drug Revenue (Million USD) by Countries (2015-2020)
Table 68. South America Hepatitis B Drug Revenue by Countries (2015-2020)
Table 69. South America Hepatitis B Drug Revenue Market Share by Countries (2015-2020)
Table 70. Middle East and Africa Hepatitis B Drug Revenue (Million USD) by Countries (2015-2020)
Table 71. Middle East and Africa Hepatitis B Drug Revenue Market Share by Countries (2015-2020)
Table 72. Global Hepatitis B Drug Revenue (Million USD) by Type (2015-2020)
Table 73. Global Hepatitis B Drug Revenue Share by Type (2015-2020)
Table 74. Global Hepatitis B Drug Revenue Forecast by Type (2021-2025)
Table 75. Global Hepatitis B Drug Revenue by Application (2015-2020)
Table 76. Global Hepatitis B Drug Revenue Share by Application (2015-2020)
Table 77. Global Hepatitis B Drug Revenue Forecast by Application (2021-2025)
Table 78. Global Hepatitis B Drug Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Hepatitis B Drug Picture
Figure 2. Global Hepatitis B Drug Revenue Market Share by Type in 2019
Figure 3. Entecavir Picture
Figure 4. Tenofovir Picture
Figure 5. Lamivudine Picture
Figure 6. Adefovir Picture
Figure 7. Telbivudine Picture
Figure 8. Others Picture
Figure 9. Hepatitis B Drug Revenue Market Share by Application in 2019
Figure 10. Hospital Pharmacies Picture
Figure 11. Retail Pharmacies & Drug Stores Picture
Figure 12. Others Picture
Figure 13. Global Hepatitis B Drug Revenue (USD Million) and Growth Rate (2015-2025)
Figure 14. North America Hepatitis B Drug Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Europe Hepatitis B Drug Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Asia-Pacific Hepatitis B Drug Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. South America Hepatitis B Drug Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Middle East and Africa Hepatitis B Drug Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Hepatitis B Drug Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. Global Hepatitis B Drug Revenue Share by Players in 2019
Figure 21. Global Top 5 Players Hepatitis B Drug Revenue Market Share in 2019
Figure 22. Global Top 10 Players Hepatitis B Drug Revenue Market Share in 2019
Figure 23. Key Players Market Share Trend
Figure 24. Global Hepatitis B Drug Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 25. Global Hepatitis B Drug Revenue Market Share by Regions (2015-2020)
Figure 26. Global Hepatitis B Drug Revenue Market Share by Regions in 2018
Figure 27. North America Hepatitis B Drug Revenue and Growth Rate (2015-2020)
Figure 28. Europe Hepatitis B Drug Revenue and Growth Rate (2015-2020)
Figure 29. Asia-Pacific Hepatitis B Drug Revenue and Growth Rate (2015-2020)
Figure 30. South America Hepatitis B Drug Revenue and Growth Rate (2015-2020)
Figure 31. Middle East and Africa Hepatitis B Drug Revenue and Growth Rate (2015-2020)
Figure 32. North America Hepatitis B Drug Revenue Market Share by Countries (2015-2020)
Figure 33. North America Hepatitis B Drug Revenue Market Share by Countries in 2019
Figure 34. USA Hepatitis B Drug Revenue and Growth Rate (2015-2020)
Figure 35. Canada Hepatitis B Drug Revenue and Growth Rate (2015-2020)
Figure 36. Mexico Hepatitis B Drug Revenue and Growth Rate (2015-2020)
Figure 37. Europe Hepatitis B Drug Revenue Market Share by Countries (2015-2020)
Figure 38. Europe Hepatitis B Drug Revenue Market Share by Countries in 2019
Figure 39. Germany Hepatitis B Drug Revenue and Growth Rate (2015-2020)
Figure 40. UK Hepatitis B Drug Revenue and Growth Rate (2015-2020)
Figure 41. France Hepatitis B Drug Revenue and Growth Rate (2015-2020)
Figure 42. Russia Hepatitis B Drug Revenue and Growth Rate (2015-2020)
Figure 43. Italy Hepatitis B Drug Revenue and Growth Rate (2015-2020)
Figure 44. Asia-Pacific Hepatitis B Drug Revenue Market Share by Countries (2015-2020)
Figure 45. Asia-Pacific Hepatitis B Drug Revenue Market Share by Countries in 2019
Figure 46. China Hepatitis B Drug Revenue and Growth Rate (2015-2020)
Figure 47. Japan Hepatitis B Drug Revenue and Growth Rate (2015-2020)
Figure 48. Korea Hepatitis B Drug Revenue and Growth Rate (2015-2020)
Figure 49. India Hepatitis B Drug Revenue and Growth Rate (2015-2020)
Figure 50. Southeast Asia Hepatitis B Drug Revenue and Growth Rate (2015-2020)
Figure 51. South America Hepatitis B Drug Revenue Market Share by Countries (2015-2020)
Figure 52. South America Hepatitis B Drug Revenue Market Share by Countries in 2019
Figure 53. Brazil Hepatitis B Drug Revenue and Growth Rate (2015-2020)
Figure 54. Argentina Hepatitis B Drug Revenue and Growth Rate (2015-2020)
Figure 55. Middle East and Africa Hepatitis B Drug Revenue Market Share by Countries (2015-2020)
Figure 56. Middle East and Africa Hepatitis B Drug Revenue Market Share by Countries in 2019
Figure 57. Saudi Arabia Hepatitis B Drug Revenue and Growth Rate (2015-2020)
Figure 58. UAE Hepatitis B Drug Revenue and Growth Rate (2015-2020)
Figure 59. Egypt Hepatitis B Drug Revenue and Growth Rate (2015-2020)
Figure 60. South Africa Hepatitis B Drug Revenue and Growth Rate (2015-2020)
Figure 61. Global Hepatitis B Drug Revenue Share by Type (2015-2020)
Figure 62. Global Hepatitis B Drug Revenue Share by Type in 2019
Figure 63. Global Hepatitis B Drug Market Share Forecast by Type (2021-2025)
Figure 64. Global Entecavir Revenue Growth Rate (2015-2020)
Figure 65. Global Tenofovir Revenue Growth Rate (2015-2020)
Figure 66. Global Lamivudine Revenue Growth Rate (2015-2020)
Figure 67. Global Adefovir Revenue Growth Rate (2015-2020)
Figure 68. Global Telbivudine Revenue Growth Rate (2015-2020)
Figure 69. Global Others Revenue Growth Rate (2015-2020)
Figure 70. Global Hepatitis B Drug Revenue Share by Application (2015-2020)
Figure 71. Global Hepatitis B Drug Revenue Share by Application in 2019
Figure 72. Global Hepatitis B Drug Market Share Forecast by Application (2021-2025)
Figure 73. Global Hospital Pharmacies Revenue Growth Rate (2015-2020)
Figure 74. Global Retail Pharmacies & Drug Stores Revenue Growth Rate (2015-2020)
Figure 75. Global Others Revenue Growth Rate (2015-2020)
Figure 76. Global Hepatitis B Drug Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 77. Global Hepatitis B Drug Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 78. Global Hepatitis B Drug Revenue Market Share Forecast by Regions (2021-2025)
Figure 79. North America Hepatitis B Drug Revenue Market Forecast (2021-2025)
Figure 80. Europe Hepatitis B Drug Revenue Market Forecast (2021-2025)
Figure 81. Asia-Pacific Hepatitis B Drug Revenue Market Forecast (2021-2025)
Figure 82. South America Hepatitis B Drug Revenue Market Forecast (2021-2025)
Figure 83. Middle East and Africa Hepatitis B Drug Revenue Market Forecast (2021-2025)
Figure 84. Sales Channel: Direct Channel vs Indirect Channel
B型肝炎治療薬の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Hepatitis B Therapeutic Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimi…- B型肝炎ウイルス（HBV）の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Hepatitis B Vir (HBV) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Hepatitis B Vir (HBV) m…
- 予防B型肝炎ウイルスワクチンの世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Prophylactic Hepatitis B Virus Vaccines market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Proph…
- C型肝炎薬の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Hepatitis C Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Hepatitis C Drugs market re…
- C型肝炎ウイルス（HCV）の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Hepatitis C Virus(HCV) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Hepatitis C Virus(HCV)…